Title: Internal QC Programs a quantitative approach
1Internal QC Programs- a quantitative approach
- Graham Jones
- Chemical Pathology
2Quality Terminology
- QA - Quality Assurance
- Planned, systematic actions providing confidence
that a quality output will be produced - Laboratory Procedures
- IQC - Internal Quality Control (QC)
- Procedures use to assess validity of results in
real time, controls release of results - QC material run with patient samples
- EQA - External Quality Assessment
- Procedures operated by an external agency which
allow retrospective review of performance - RCPA-AACB
3Internal QA
- An Internal Quality Assurance (IQA) program is a
tool to assist with maintenance of correlation
between different analysers in the same
laboratory. - Our IQA program includes the following features
- frequent sample distributions (2-3 pairs per
week) - the use of patient samples to reduce matrix
effects - unknown values at the time of measurement
- a range of values to cover the measurement range
- result review occurring at some stage after
analysis - We have developed a spreadsheet application to
allow user friendly review of results.
4QC Issues
- Selection of material (matrix)
- Selection of levels (decision points)
- Setting of targets and ranges
- Decision on frequency (batch vs RA)
- Decision on number of QC samples (n)
- Response to out-of-range values
- Quality planning
5What is the aim of QC?
- To ensure that results released are OK
- To identify when the assay is not performing
satisfactorily - Question
- How good do we need to be to be OK?
6QC Variables
- Batch assays
- With run
- Accept or reject whole batch
- Random Access
- Hold results, run QC, then release results
- Run and release results, run QC
- If QC fails, may need to re-run previous results.
7QC Design
- Bench Level
- Simple, reproducible procedure to ascertain
acceptability of current functioning. - Knowledge of basic procedures to correct problems
- Supervisor Level
- Knowledge of whole Quality Assurance
- Link effects of QC to patient results
- Set up and administer system
8What does a result mean
- A single result means that the actual value has a
95 chance of lying within /- 2SD of that result
(SD of assay at that level) - Performing replicates narrows the range within
which the actual value is likely to lie.
(Standard error of the mean, SD/vn) - Applies to QC as well as patient samples
SEM
/- 2SD
9Levy-Jennings Plots
3SD
- When in control
- Centered around Mean
- Only outside 2SD 5
- Outside 3SD lt1
2SD
Mean
-2SD
-3SD
TIME
10Levy-Jennings Plots
3SD
2SD
Mean
-2SD
Shift in Mean
-3SD
Shift in SD
11Assay failure
- Assay change by
- Change in Mean (A)
- Change in SD (B)
- Blunders
- Usual QC programs best at detecting shifts in
mean
A
B
12Interpreting Results
- One result 2 SD from the mean
3SD
2SD
Mean
-2SD
-3SD
13QC results - Examples
- A QC result at 2 SD of assay performance
- 5 chance that the result reflects normal assay
performance - 50 chance that true result (mean) is above
that value (ie assay has changed by gt2SD)
14QC results - Examples
- A QC result at 10SD of assay performance
- 0 chance that the result reflects normal assay
performance - 100 chance that true result represents change
in assay mean (ie assay mean has changed by gt7 SD)
15QC - improving power to detect changes
- To improve the probability of detecting a change
assay performance - one QC further from the mean (eg gt3SD)
- see more QC values gt2SD
- Principle Certainty of a true change is
increased by - A result further from the mean
- More results showing the same deviation
16Being sure that the assay has changed
- Many results a bit different
- One result very different
3SD
2SD
Mean
-2SD
-3SD
17Multi-rules
- Looks at many results
- eg
- 1 x 3S (one value gt3SD from mean)
- 2 x 2S (2 values gt2 SD from mean)
- 4 x 1S (4 values gt1 SD from mean)
- All may indicate a significant shift in the assay
mean - Increases chance of finding an error.
18Summary thus far
- Big Shifts
- Easy to detect
- High probability of detection
- Can use simple rules with few QC samples
- Little shifts
- Hard to detect
- Low probability of detection
- Use multi-rules with many QC samples
- Hard to detect shifts of less than 2.5 SD
19Westgard - Quantifying QC
- Process of quantifying power of QC to detect
changes - Based on Levy-Jennings plots
- If the mean shifts by X, what chance is there
that my QC process will detect the change - or
- With my current QC process, what changes can I
reliably detect
20Terminology
- n - number of QC samples run together
- (commonly n2 for Chemistry, often n3 for
Immunoassays) - 1 3s - 1 QC result gt3 SD from the mean
- 2 2s - 2 QC results gt2 SD from mean
- 4 1s - 4 QC results gt 1 SD from mean
- Multi-rules can be within run (across material)
or same material (across runs) - 3of4 1s - 3 out of 4 gt1 SD from mean
21Original Westgard Multi-rules
22www.westgard.com/
23Westgard - QC Quantitation
3SD
2SD
Mean
-2SD
-3SD
24Power Function Graphs
P- ED
P- FR
25Power Function Graphs
P- ED
P- FR
26Power Function Graph (n2)
12s
12.5s
MR
13.5s
27Power Function Charts (1 3s)
n8
n4
n1
28Power Function Charts - Summary
- Allows quantitation of assay shifts which can be
detected for various QC protocols - Variables
- n, rules
- Shows probability of detecting change
- Can allow choice of QC protocols to detect
certain errors
29Shifts and Results
- An assay may produce results up to 2SD from the
true value when working well. - If the mean shifts by 2 SD, results may be
produced up to 4 SD from the true value - If we can detect a shift of 3SD 90 of the time,
then when undetected, a 5SD error may be released
2.5 of the time
2SD
30QC Goals
- Do we want to identify statistically significant
changes in assay performance? - or
- Do we want to measure clinically important
changes in assay performance? - Eg is a 2 change in an amylase result worth
fixing!
31SydPath QC Protocol
- 4) Interpretation
- In response to the QC results, one of three
options can be chosen - 1. CONTINUE - continue without change
- 2. PAUSE - Stop releasing results -
troubleshoot assay and continue when fixed - 3. STOP - Stop releasing results - troubleshoot
assay, rerun previous samples if assay changed
(Re-run not required when problem is shown to be
due to QC material).
32SydPath QC Protocol
- If both QC in Range (lt2LSD) CONTINUE
- If either (of 2) QC ? 3LSD STOP
- If 2 (of 2, High and Low) QC ? L2SD STOP
- If 1 (of 2) QC ? 2LSD and lt3LSD - stop releasing
results, repeat High and Low QC for that analyte - If, of the repeat QC results
- Either QC ? 3LSD STOP
- Both QC ? 2LSD STOP
- Either QC ? 2LSD PAUSE
- Otherwise CONTINUE
- These rules have the power to cause a STOP 90 of
the occasions when there is a shift in the assay
of 2.8 x LSD and cause a PAUSE 90 of the
occasions when there is a shift in the assay of
2.6 x LSD.
33SydPath QC
- Rerun Protocol
- Choose 5-10 previous samples measured since the
previous in-control QC. - Re-analyse once assay fixed.
- Compare original results and change in computer
if results significantly different. - If all samples re-run are different, re-run
earlier samples until correct results obtained. - Decisions about significant differences to be
based on CAL Re-Run Protocol . Refer to CAL
Result Change Assessment Chart (based on
RCPA-AACP EQA Allowable Limits of Performance). - If a change is required to a previously released
result which may have been seen by a clinician
1) Inform the requesting Doctor of any
clinically significant change of results. - 2) Enter the new result in place of the
previous result and insert the following
footnote - "AAAAA Following re-analysis, result changed
from previously reported value of BBB at CCCC
on DD/DD/DD. EEEE informed of change in result."
34Change Protocol
In the event of re-running an assay following the
suspicion of an analytical error, significant
changes must be changed in the computer and
notified to the requesting/treating doctor.
Changes equal to, or greater than those shown
below may be considered significant (these values
based on the RCPA-AACB Allowable limits of
performance). If in doubt, consult the
Pathologist or Senior Scientist.
35The Reverse Process - Capability
- Identify Analytical Goals
- Agreed clinical targets
- RCPA-AACB Allowable Limits of Performance (ALP)
- CLIA targets
- Set up a QC program which has a high probability
of detecting an error this size together with a
low false-rejection rate.
36Capability - Quantitative Tests
/- 2 SD
- Actual variation compared to
- clinically required variation
- SD of QC material compared
- to Allowable Limits of
- Performance (ALP)
- CpALP/SD
/- ALP
37Capability
Cp 6
2.5 SD Shift
2 SD spread
Cp 4
Cp 3
ALP
38Capability
- Good assays (capable) have an analytical
performance (SD) which is much less than the
clinically important change. - This can be quantified as the Capability index
CpALP/SD - (ALPAllowable limit of Performance)
- gt6 great
- 4-6 OK
- lt4 poor
39Capability in practice
- Capable assays can use different QC to less
capable assays - Eg
- Simpler rules
- Less QC runs
- Can also set tighter limits to correct a true
change in the assay performance before it is bad
enough to stop releasing results.
40Capability
- Assays may be poor because of
- The laboratory
- The method
- The industry
- If
- Lab trouble-shoot
- Method consider changing method
- Industry wait!
41Setting Ranges for QC
- Actual SDs are difficult to determine exactly
(which results to exclude) - Actual SDs change over time
- But need to put limits into instruments as mean
/- 2SD to fixed sig figs - Suggest
- Actual SD (ASD, measured SD)
- Limit SD (LSD, put into QC package)
42Chemical Pathology
- Run-in new QC for urine and serum
- Set target ranges
- Assess power to detect errors of current process
- Future
- Review performance
- Target poor assays
- adjust n, rules, frequency
43Summary
- Some aspects of QC can be quantified
- This process allows us to use appropriate QC
- can either
- Know how good we are
- or
- Aim to reach certain targets